Home / Blog / Blog
Blog

Private label female suppositories from inquiry to shipment: process steps and list of parameters to be confirmed

This article is intended for brand owners planning to launch vaginal tightening suppositories under a private label. It outlines the dosage form boundaries of SELUNIVA YP-3, the scope of modifications for private label and OEM/ODM, the six milestones from inquiry to shipment, and which parameters can be directly determined and which must be confirmed item by item in conjunction with the target market. The core conclusion is: when the target market, label wording, and trial order pace are already clear, private label can solve specific problems; when the requirements are still drifting, it is more prudent to first validate with the standard version.

2026-09-27About 8 min read
Private label female suppositories from inquiry to shipment: process steps and list of parameters to be confirmed
Blog Blog

What is the SELUNIVA YP-3 private label female suppository: first distinguish the dosage form, ingredients, and customizable boundaries

YP-3 is asuppository for vaginal administration, not an external cleansing gel or wash. During use, it needs to be inserted into the vagina, where it gradually disintegrates and releases relying on body temperature and secretions. This dosage form difference directly determines the subsequent product positioning, packaging method, and compliance communication direction—if you originally wanted a douching or topical care product, YP-3's form and usage logic do not match.

In terms of category attribution, it is placed under the Yoni Pops suppository category, uses a boric acid formula, is positioned for vaginal cleansing and dryness repair, and is described as using natural herbs as raw materials. Place of origin: Shaanxi; brand: SELUNIVA; in stock; supports OEM/ODM. It should be noted that these are descriptions at the product positioning level. Specific parameters that directly affect user experience and compliance filing, such as ingredient ratios, individual suppository specifications, disintegration time, and pH value, have not been provided at present and need to be confirmed item by item with the SELUNIVA team.

Boric acid suppositories under the Yoni Pops category: differences from ordinary cleansing and care products

Comparing YP-3 with ordinary cleansing and care products, the core difference is not in the word "cleansing," but in the mode of action and the site of contact:

  • Administration method: suppositories are inserted internally, while cleansing and care products are mostly for external use or douching.
  • Core formula: YP-3 uses boric acid as the main formula component, while ordinary care products usually rely mainly on surfactants, plant extracts, or moisturizers.
  • Functional claims: YP-3 focuses on vaginal cleansing and dry repair, falling within the scope of gynecological care applications, rather than daily bathing or intimate cleansing.

This means that when selecting products, YP-3 cannot be treated as an ordinary intimate care product by applying ready-made labels, copy, and listing categories. Its dosage form determines that the target users, usage instructions, and compliance pathways are all narrower and more specific.

What private label and OEM/ODM can each change on YP-3

These two are often used interchangeably, but on YP-3 they correspond to different depths of modification:

Private Label—The product itself basically continues to use the existing formula and dosage form; what you mainly change is the brand layer: brand name, packaging design, label information, and outer box copy. It is suitable for situations where you already have a clear brand and only want to quickly list products under your own identity.

OEM/ODM—The scope of modification is deeper, usually involving formula adjustments, specification customization, dosage form details, or redefinition of the functional direction. It is suitable for situations where the existing formula does not fully fit your target market or user needs and requires product differentiation.

To decide which one to choose, ask yourself three questions: Is the existing boric acid formula and the "cleaning + dry repair" positioning exactly what you want to sell? Does your target market have additional restrictions on the labeling and claims of boric acid suppositories? What minimum order quantity and development timeline can you accept?

The first two questions determine whether the formula needs to be changed, and the third determines whether private labeling or OEM/ODM is more cost-effective for you.

Whichever path you take, the following parameters need to be confirmed clearly with the SELUNIVA team during the inquiry stage, because they affect cost, compliance, and subsequent maintenance at the same time:

  • Single-unit specifications and the number of units per box
  • Boric acid content and the full ingredient list
  • Disintegration method and recommended usage cycle
  • Customizable packaging formats and minimum order quantity
  • Labels and compliance documents required by the target market

Most of this information is currently not publicly available. It is not that there is a problem with the product, but rather that customized products naturally need to be matched to your specific conditions. Clarify the usage scenario, target market, and expected quantity first, then have the team provide the corresponding solution. This is more efficient than looking at the parameter table first.

What are the six steps from inquiry to shipment: what parameters should be confirmed with SELUNIVA at each stage

Private label female suppositories typically advance through six steps from inquiry to shipment: requirement confirmation, formula and samples, packaging and label confirmation, document preparation, mass production, and shipment. The sequence is fixed, but the parameter values for each step must be confirmed with SELUNIVA through inquiry; this article does not provide specific values.

Requirement confirmation and formula sample stage: which inputs to lock down first

The first step is requirement confirmation, starting by locking down the target market (the United States, Canada, Europe, Australia), sales channel, intended use, and whether to continue using the existing YP-3 boric acid formula. MOQ and trial order policies should also be clarified at this step, because they determine whether subsequent formula and packaging customization is worth the investment.

The second step is formula and samples, where the sample form, sample cost, sample lead time, and scope of formula adjustments need to be confirmed. The sample stage is a key window for filtering out vague answers: if the supplier cannot explain the relationship between the boric acid source and the "100% natural herbal" claim, subsequent compliance risks will be magnified.

Packaging and labeling, documents, mass production, and shipment stage: which parameters must be confirmed in writing

Step 3: Packaging and labeling confirmation. It is necessary to confirm the packaging format, label elements, and claim wording, and to clarify the scope of documents the supplier can provide. Step 4: Document preparation. The available scope of ingredient declarations, label documents, and test reports must be confirmed item by item; do not delay this until after mass production.

Step 5: Mass production. MOQ, trial order policy, mass production lead time, and payment terms all need to be confirmed through inquiry. Step 6: Shipping. The shipping method, packaging protection, and accompanying documents need to be confirmed. It is recommended to fix the confirmation results of each node in writing before proceeding to the next step.

Which parameters must be confirmed through inquiry and which can be directly determined: YP-3 parameter checklist

The parameters of YP-3 fall into two categories: one category is already stated in the product materials and can be directly determined;the other category depends on your market, packaging, and order rhythm, is not provided in the materials, and must be confirmed with SELUNIVA. Handling them separately can avoid asking the wrong questions and also avoid treating unconfirmed numbers as established facts.

Parameters that can be judged directly based on product information: model, place of origin, material, composition, and function

The following information is clearly stated in the YP-3 product information and can serve as a basis for preliminary judgment:

ParameterDescription in the information
BrandSELUNIVA
ModelYP-3
Place of OriginShaanxi, China
MaterialBoric Acid
Ingredients100% Natural Herbal
FunctionVaginal cleansing, dry repair
ApplicationFemale gynecological care
Usage methodInsert as a vaginal suppository
OEM/ODMAvailable
StockIn stock

These parameters answer the question of "what product this is and whether private labeling is possible." If your core question is whether the category and formulation direction match, just look at the materials; there is no need to inquire first.

Parameters that must be confirmed with SELUNIVA: MOQ, trial orders, lead time, costs, and documents

The following parameters are not provided in the materials and are highly dependent on your target market and your own pace, so you cannot make assumptions on your own:

  • MOQ and trial orders: minimum order quantity, whether trial orders below the MOQ are accepted, and whether trial order pricing differs from that of formal orders
  • Lead time: in-stock shipping cycle, private label customization cycle, and whether it is extended during peak season
  • Costs: Whether sampling fees, packaging printing fees, and plate fees are listed separately and whether they can be deducted from subsequent orders
  • Documents: What accompanying documents are required for customs clearance or listing in the target markets (the United States, Canada, Europe, Australia), and who issues them
  • Labels and compliance: What local requirements must the ingredient and function claims on private label labels meet, and to what extent can SELUNIVA provide them

What these questions have in common is that the answers are not in the product itself, but in your order terms and the rules of your target market. Asking directly is cheaper than reworking later. This article does not provide any numerical commitments; all numerical values are subject to the supplier's written reply.

When it is appropriate to proceed with private labeling and when it is not worth adding complexity: conclusions and boundaries

Private label cooperation adds not just the labeling action, but the entire chain of formula confirmation, packaging materials, label compliance, and delivery rhythm. SELUNIVA's YP-3 belongs to the Yoni Pops category, with a boric acid formula, focusing on vaginal cleansing and dryness repair, and supports OEM/ODM. Whether it is worth proceeding depends on whether your goals have been narrowed down to an executable scope.

Recommended scenarios for proceeding: clear goals, clear documentation requirements, and a trial order verification rhythm

  • Clear target market and audience: Determine that it targets one of the markets among the United States, Canada, Europe, or Australia, and clearly understand that it is for home women's care scenarios.
  • Documentation requirements can be listed clearly in advance: label language, ingredient statements, and packaging format can be confirmed before sampling, rather than being changed on the fly.
  • There is a trial-order validation rhythm: willing to first use small batches to validate channel feedback, then decide whether to scale up.
  • Can accept the functional boundaries of the formula: acknowledges that the boric acid formula corresponds to the cleaning and dry repair direction, and does not require it to make promises beyond that scope.

Scenarios not recommended or that should first be simplified: vague goals, insufficient materials, frequently changing expectations

  • The goal is still drifting: If you pursue a firming concept today, switch to pure cleansing tomorrow, and change the target audience the day after, private label will only amplify uncertainty into inventory and packaging material waste.
  • Key information is incomplete: If you cannot clearly explain the target market's labeling requirements, ingredient disclosure standards, or packaging specifications, rework is highly likely midway through.
  • Expectations change frequently: If you haven't even decided "what this batch is validating," it's more cost-effective to start with ready stock or standard products for testing.
  • The budget can only cover one attempt: Private label upfront investment is usually higher than ready stock; if the budget doesn't allow for trial and error, the complexity isn't worth it.

Budget allocation and conclusion boundaries

The budget recommendation is divided into three stages: "compliance and document preparation—samples and packaging—mass production and logistics": first confirm the documents and labeling requirements needed for the target market, then invest in sample and packaging design, and finally decide the mass production scale based on the trial order results. Specific amounts, MOQ, and costs all need to be confirmed by inquiring with the supplier; this article does not provide numerical commitments.

Conclusion boundaries:When private labeling can solve a main problem you have already clearly identified, proceed;when it only makes the plan look more complete, simplify first. If it involves more complete formula customization or higher collaboration complexity, then evaluate an upgrade plan.

If you are unsure whether your goals, materials, or expectations have reached a level that can be advanced, you can organize these three items and consult the SELUNIVA team.

Frequently asked questions

Q: I only want to do a small-batch trial order. Is SELUNIVA private labeling still worth it? It is worth it on the premise that the trial order has clear goals, such as validating a certain packaging format or label wording. If you are only testing sales, stock items or standard models are usually faster.

Q: The target market has not been finalized yet. Can we proceed with private labeling first? Not recommended. Different markets have different requirements for labels and ingredient statements. If the market is undecided, packaging materials and copy will be revised repeatedly, and the cost will actually be higher.

Q: How should the boric acid formula of YP-3 and the concept of "firming" be understood? Product information shows that its functional direction is vaginal cleansing and dry repair, and it belongs to the Yoni Pops category. How private label copy should be worded must be confirmed with the SELUNIVA team in light of the target market rules.

Q: What signals indicate that I should go back from private label to the standard model? When you find yourself repeatedly changing the audience, changing the function description, and changing the packaging specifications, and each change overturns the previous version, it means the requirements are not yet stable, and it is safer to go back to the standard model for validation first.

Learn more

If you can already clearly state the target market, the required documents, and the expected quantity, you can organize these three pieces of information and send them to the SELUNIVA team. Based on that, we will match the corresponding private label or OEM/ODM solution and provide node suggestions for sampling and mass production.

Private label female suppositories from inquiry to shipment: process steps and list of parameters to be confirmedPrivate Label Organic Vaginal TighteningBoric acid formula with vaginal detoxInsert as vaginal suppositories.SELUNIVA Private Label Organic Vaginal Tightening Suppositories (Model YP-3) belong to Yoni PopsPrivate Label Vaginal Suppository ProcessPrivate Label Suppository Spec SheetVaginal Suppository OEM InquiryYP-3 Boric Acid SuppositoryPrivate Label Suppository MOQ Confirmation
FacebookInstagram